Alamar Biosciences, Inc. (ALMR)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · ALMR
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
No current thesis-health read is available for this company.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -9.5% |
| Our one-year growth estimate | diamond | Not available |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 65 industry peers · Company calendar date is not available
ALMR — CEO transition
Dated 2026-11-03
President — Timothy “Tod” White: The President is retiring after five years with a planned transition period and positive remarks from the CEO, indicating an orderly succession rather than a sudden loss.
Why it matters: The filing is labeled an earnings beat, but its summary gives no results or figures. A full report could show how strong the beat was.
Watch forA company report gives figures that top its stated outlook.
Also watch forA company report gives figures below its stated outlook, or does not beat it.
Why it matters: This is the next stated date for a company update. No transcript or guidance details were provided.
Watch forThe November 3 report gives business results or guidance that can be measured. They improve on the prior report.
Also watch forThe report gives weaker results or guidance than the prior report, or delays the update.
Why it matters: The sector report says growth is slowing and names revenue growth as a key driver. ALMR-specific results were not provided.
Watch forThe sector's reported three-year revenue growth rises from near 9% toward its prior highs.
Also watch forThe sector's reported three-year revenue growth falls further below near 9%.
Why it matters: New board members can change company strategy and rules. This can affect future results.
Watch forNew director's plans lead to a strategy change that improves company results.
Also watch forNo clear changes in strategy or results after the new director starts.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$336 on $10,000 · ±3.4% | How much price usually moves either way. |
| Bad day | $816 loss on $10,000 · 8.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,832 loss on $10,000 · 38.3% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.